Alembic Pharmaceuticals Ltd has received final approval from the US Food and Drug Administration for prazosin hydrochloride capsules USP in 1 mg, 2 mg, and 5 mg strengths, the company said in an exchange filing.
The drug is a generic version of Pfizer Inc's Minipress capsules.
It is indicated for the treatment of hypertension to lower blood pressure.
According to data by IQVIA, the drug had sales of approximately $50 mln for the 12-month period ended December.
India Introduces E-Passports: Enhanced Data Security And Fraud Prevention; India Joins 120 Countries In Enhancing National Security
India Strongly Condemns Killing Of Israeli Embassy Staffers In Washington
SHOCKING! Hundreds Of Parrots Die In Jhansi After Massive Storm Hits Various Parts Of UP (VIDEO)
Telangana: BRS Leader KT Rama Rao Slams CM Revanth Reddy Over Miss World Events Amid Farmer Suicides, Alleges Misplaced Priorities
Shares of the company traded 0.8% lower at ₹521.05 on the NSE, at 09:15 IST.
